Ariadne Diagnostics is Biotechnology in United States that focus on development services business. Founded in 2011. They cover business area such as diagnostic discovery, development, novel biomarker panel, prognostic, predictive test, area, unmet medical need, advanced bioinformatics tool, genomic, proteomic, cellular and clinical datum, candidate biomarker, drug agent, individual patient, case, neuromuscular and neurodegenerative disease.
2011
( 13 years old in 2024 )
Development Services
-
12 South Summit Avenue
Suite 200
Gaithersburg, MD 20877
United States
Private
diagnostic discoverydevelopmentnovel biomarker panelprognosticpredictive testareaunmet medical needadvanced bioinformatics toolgenomic, proteomic, cellular and clinical datumcandidate biomarkerdrug agentindividual patientcaseneuromuscular and neurodegenerative disease
* We use standard office opening hours in near Ariadne Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ariadne Diagnostics is Biotechnology business from United States that founded in 2011 (13 years old in 2024), Ariadne Diagnostics business is focusing on Development Services.
Ariadne Diagnostics headquarter office and corporate office address is located in 12 South Summit Avenue Suite 200 Gaithersburg, MD 20877 United States.
Ariadne Diagnostics was founded in United States.
In 2024, Ariadne Diagnostics is currently focus on development services sector.
Above is snippet of Google Trends for "development services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ariadne Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
